← FDA DRUG APPROVALS
FDA ANDA · ANDA072758
TRIPROLIDINE AND PSEUDOEPHEDRINE HYDROCHLORIDES
Sponsor: KV PHARM
APPLICATION
ANDA072758
TYPE
ANDA
ROUTE
ORAL
DOSAGE FORM
TABLET, EXTENDED RELEASE
MARKETING STATUS
Discontinued
Products
TRIPROLIDINE AND PSEUDOEPHEDRINE HYDROCHLORIDESDiscontinued
PSEUDOEPHEDRINE HYDROCHLORIDE 120MG, TRIPROLIDINE HYDROCHLORIDE 5MG · TABLET, EXTENDED RELEASE · ORAL
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.